XML 57 R46.htm IDEA: XBRL DOCUMENT v3.23.1
TRADING AND AVAILABLE-FOR-SALE SECURITIES AT FAIR VALUE (Tables)
12 Months Ended
Mar. 31, 2022
Debt Securities, Trading, and Equity Securities, FV-NI [Abstract]  
Schedule of trading and available-for-sale securities
As of March 31, 2022 and 2021, trading and available-for-sale securities consisted of:
March 31, 2022March 31, 2021
(recast)(recast)
Corporate debt$662,416 $301,899 
Non-US sovereign debt342,786 239,630 
Corporate equity64,023 39,279 
US sovereign debt10,306 4,661 
Exchange traded notes1,451 2,077 
Total trading securities$1,080,982 $587,546 
  
Equity securities
Total available-for-sale securities, at fair value$$
Schedule of present securities assets at fair value
The following tables present trading securities assets in the Consolidated Financial Statements or disclosed in the Notes to the Consolidated Financial Statements at fair value on a recurring basis as of March 31, 2022 and 2021:
Weighted
average
interest rate
Total
Fair Value Measurements at
March 31, 2022 (recast) using
Quoted Prices in Active
Markets for Identical
Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant unobservable
units
(Level 3)
Corporate debt9.61 %$662,416 $661,821 $— $595 
Non-U.S. sovereign debt13.11 %342,786 334,491 — 8,296 
Corporate equity— 64,023 63,496 275 251 
U.S. sovereign debt2.36 %10,306 10,306 — — 
Exchange traded notes— 1,451 1,451 — — 
Total trading securities$1,080,982 $1,071,565 $275 $9,142 
Equity securities $$— $— $
Total available-for-sale securities, at fair value$$— $— $
Weighted
average
interest rate
Total
Fair Value Measurements at
March 31, 2021 (recast) using
Quoted Prices in Active
Markets for Identical
Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant unobservable
units
(Level 3)
Corporate debt9.22 %$301,899 $301,539 $— $360 
Non-U.S. sovereign debt8.06 %239,630 239,630 — — 
Corporate equity— 39,279 20,606 — 18,673 
U.S. sovereign debt1.68 %4,661 4,661 — — 
Exchange traded notes— 2,077 2,077 — — 
Total trading securities$587,546 $568,513 $— $19,033 
Equity securities — $$— $— $
Total available-for-sale securities, at fair value$$— $— $
Schedule of valuation techniques and significant level 3 inputs
The table below presents the Valuation Techniques and Significant Level 3 Inputs used in the valuation as of March 31, 2022 and 2021. The table is not intended to be all inclusive, but instead captures the significant unobservable inputs relevant to determination of fair value.
Type
Valuation
Technique
FV as of March 31,
2022 (recast)
FV as of March 31,
2021 (recast)
Significant Unobservable Inputs%
   
Corporate equityDCF$— $18,370 Discount rate10.6%
Estimated number of years9 years
Corporate equityDCF$251 $303 Discount rate20.0%
Estimated number of years9 years
Corporate debtDCF$595 $360 Discount rate45.0%
Estimated number of years3 months
Non-US sovereign debtDCF$7,524 $— Discount rate69.0%
Estimated number of years11 years
Non-US sovereign debtDCF$772 $— Discount rate13.9%
Estimated number of years1 year
$9,142 $19,033 
As of March 31, 2022, shares of SPBX held by the Company were transferred from level 3 to level 1, due to active trades on the market. During the year ended March 31, 2022, market trades of SPBX shares were executed in the market, and market data for these shares became available.
The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended March 31, 2022:
Trading
securities
Available-for-sale
securities
Balance as of March 31, 2020 (recast)
$11,259 $
 
Sale of investments that use Level 3 inputs (2)— 
Purchase of investments that use Level 3 inputs736 — 
Revaluation of investments that use Level 3 inputs7,040 — 
Foreign currency translation— — 
Balance as of March 31, 2021 (recast)
$19,033 $
 
Reclassification to level 3682 — 
Reclassification to level 1(18,371)
Purchase of investments that use Level 3 inputs10,812 — 
Revaluation of investments that use Level 3 inputs(3,014)— 
Foreign currency translation— — 
Balance as of March 31, 2022 (recast)
$9,142 $
Schedule of amortized cost, unrealized gains and losses accumulated in other comprehensive income, and fair value of available-for-sale securities
The table below presents the amortized cost, unrealized gains and losses accumulated in other comprehensive income, and fair value of available-for-sale securities as of March 31, 2022 and 2021:
March 31, 2022 (recast)
Assets
measured at
amortized cost
Unrealized loss
accumulated in other
comprehensive
income
Assets
measured
at fair value
Equity securities $$— $
Balance as of March 31, 2022
$$— $
March 31, 2021 (recast)
Assets
measured at
amortized cost
Unrealized loss
accumulated in other
comprehensive
income
Assets
measured
at fair value
Equity securities$$— $
 
Balance as of March 31, 2021
$$— $